Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Carl D Novina, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Carl Novina and Anthony Letai.
Connection Strength

0.091
  1. Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest. 2007 Jan; 117(1):112-21.
    View in: PubMed
    Score: 0.091
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.